Cited by 10Healthcare Policy and ManagementPrimary Care and Health OutcomesHealthcare Quality and Management

Alternative Payment Models and Performance in Federally Qualified Health Centers

Open access
Markowski, Justin, Wallace, Jacob, Schlesinger, Mark, Ndumele, Chima D.·2024·JAMA Internal Medicine

Abstract

Importance: Several state Medicaid agencies have transitioned from traditional fee-for-service to a value-centric alternative payment model (APM) to reimburse federally qualified health centers (FQHCs). Little is known about the effects of this shift on FQHC performance. Objective: To assess the association between APMs and the clinical performance, payer mix, risk profile, and financial sustainability of FQHCs. Design, Setting, and Participants: This retrospective cohort study was performed in 684 FQHCs (representing 37 states plus the District of Columbia) that continuously operated between January 2009 and December 2021. Data on payer mix (eg, type of insurance) and risk profile (eg, proportion of patients with chronic conditions) of FQHC patients were obtained from the Uniform Data System, and clinic-level financial data (eg, revenue) were obtained from Internal Revenue Service form 990 tax documents. Data were analyzed between November 2022 and October 2023. Exposure: Initial rollout of a value-based payment model (ie, an APM) for FQHCs, as offered by state Medicaid program, between January 2013 and December 2021. Main Outcomes and Measures: The main outcomes were 4 audited process measures of health care quality (cervical and colorectal cancer screening and body mass index [BMI] assessment for adults and children) and 2 intermediate health outcome measures (hypertension control and diabetes control). A difference-in-differences design was used with staggered implementation comparing FQHCs before and after the initial APM rollout vs contemporaneous changes in FQHCs in states without APMs. Results: A total of 684 FQHCs (8892 FQHC-years) that served 17 823 959 patients in 2021 (57.3% female) were included in the study. Among FQHCs in states implementing APMs, significant differential increases in 3 of the 4 process quality measures were observed compared with FQHCs in states that did not implement an APM: colorectal cancer screening (3.24 percentage points [pp]; 95% CI, 1.40-5.08 pp), adult BMI (3.19 pp; 95% CI, 0.70-5.68 pp), and child BMI (4.50 pp; 95% CI, 1.83-7.17 pp). There were also modest differential improvements in blood pressure control for individuals with hypertension (1.02 pp; 95% CI, 0.04-2.00 pp) and blood glucose control for individuals with type 2 diabetes (1.02 pp; 95% CI, 0.02-2.02 pp) compared with FQHCs in states without an APM. There was no evidence that the APM rollout was associated with clinics selecting healthier patients (–0.01 pp; 95% CI, –0.21 to 0.19 pp) or stinting on care (–0.02 visits; 95% CI, –0.08 to 0.04 visits). Conclusions and Relevance: In this cohort study, introduction of Medicaid APM options for FQHCs was associated with modest, statistically significant increases in quality concentrated among FQHCs with APM models that explicitly incentivized quality. This finding suggests that APMs can be both a financially viable and a health-promoting model for reimbursement in the health care safety net.

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2024.2754

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [11]11. Ma C to A. Health Care Payment Systems: Cost and Quality Incentives. Journal of Economics & Management Strategy. 1994;3(1):93-112. doi:10.1111/j.1430- 9134.1994.00093.x · DOI
  2. [21]21. de Chaisemartin C, D'Haultfoeuille X. Difference-in-Differences Estimators of Intertemporal Treatment Effects. Published online March 2022. doi:10.3386/w29873 · DOI

Cited by

Sorted by citations

Authors
Markowski, J., Wallace, J., Schlesinger, M., & Ndumele, C. D.
Affiliations
Yale University (US)
Corresponding author
Markowski, Justin
Venue
JAMA Internal Medicine
Published
2024-09-01
Volume
184
Issue
9
Pages
1065
ISSN
2168-6106 (ISSN-L)
OpenAlex
W4400414263
Cited by
10
References
28
Citations by year
2026: 6 · 2025: 4
FWCI
3.53
Type
journal article
Language
en
Open access
Locations
  • JAMA Internal Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
  • Health Sciences › Health Professions › General Health Professions › Primary Care and Health Outcomes
  • Health Sciences › Health Professions › Health Information Management › Healthcare Quality and Management
Keywords
alternative payment models, value-based payment, federally qualified health centers, Medicaid reimbursement, quality of care, colorectal cancer screening, cervical cancer screening, hypertension control, diabetes management, payer mix, risk profile, financial sustainability, fee-for-service, models of care, community health centers, state Medicaid programs, rural health care, health disparities
MeSH terms
Female, Humans, Male, Medicaid, Reimbursement Mechanisms, Retrospective Studies, United States, Fee-for-Service Plans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review